Ms. Dordal et al., DECREASED INTRACELLULAR COMPARTMENTALIZATION OF DOXORUBICIN IN CELL-LINES EXPRESSING P-GLYCOPROTEIN, The Journal of pharmacology and experimental therapeutics, 271(3), 1994, pp. 1286-1290
After initial rapid [C-14]doxorubicin distribution into drug-sensitive
HL-60 and SU-4 cells, slow uptake continues for more than 4 hr, accou
nting for up to 80% of the total intracellular drug. In contrast, in P
-glycoprotein-expressing drug-resistant HL-GOR and SU-4R cells, doxoru
bicin distribution rapidly approaches equilibrium. The simplest kineti
c model of this behavior consists of rapid diffusion from extracellula
r fluid into the cell, followed by uptake into a nonexchangeable intra
cellular pool. At 3.4 mu M doxorubicin, transmembrane diffusion cleara
nce was similar for all cell lines (0.78-0.98 mu l sec(-1)). There was
no decrease in the normalized apparent volume of distribution in the
P-glycoprotein-expressing cell lines, as would be expected if an activ
e, unidirectional efflux were present. However, in resistant cells, do
xorubicin accumulation in the nonexchangeable pool was up to 15-fold s
lower than in sensitive cells (0.004 vs. 0.050 mu l sec(-1) in HL-GOR
vs. HL-60; 0.004 vs. 0.058 mu l sec(-1) in SU-4R vs. SU-4). No pool in
flow could be detected in sec either SU-4 or SU-4R cells exposed to do
xorubicin at 0 degrees C, indicating that the nonexchangeable accumula
tion requires energy. The process preventing accumulation began to sat
urate in SU-4R cells at 20 mu M doxorubicin, whereas no evidence of sa
turation was seen with HL-60R, which is more highly resistant than SU4
R. We propose that alteration in compartmentalization is primarily res
ponsible for the doxorubicin resistance observed in these cell lines.